Ensuring All Patients

Injection Medication Adherence is only 50%

Medication non-adherence leads to 10% of U.S. hospitalizations

Medication non-adherence costs global pharma $630B in lost revenue

UniPen.A therapeutic agnostic injection safety device

Designed to improve the patient injection experience with a goal to increase medication adherence and limit the development, expense, and regulatory burdens of injectable products.

Learn More

Unipen use video

CAUTION - Investigational device. Limited by Federal law to investigational use.

Partners, Collaborators, & Supporters.

Click the logo above for a video about us

About us

At Love Lifesciences, we are dedicated to revolutionizing the patient injection experience for those requiring chronic injection therapeutics.

Our team has been developing a series of therapeutic agnostic injection safety devices that not only target improvements to the experience for patients but also target reductions in the cost of early implementation for pharmaceutical partners.

meet the team